HIV
Demonstrating Discontent, May 21, 1990
Demonstrating Discontent, May 21, 1990
Andrea Anderson | Jul 17, 2017
Activists demanded greater access to and involvement in clinical research for AIDS treatments—and their protests were heard.
Study: New Test Can Unearth Elusive HIV
Study: New Test Can Unearth Elusive HIV
Aggie Mika | May 29, 2017
The assay screens for latent virus that has the capacity to activate if antiretroviral therapy stops.
HIV Vaccines May Help Tamp Down Virus
HIV Vaccines May Help Tamp Down Virus
Kerry Grens | Feb 24, 2017
A fraction of HIV patients in a small, uncontrolled study were able to stop antiretroviral therapy after receiving the immune boosters.
Unique Antibodies Open Path Toward New HIV Vaccines
Unique Antibodies Open Path Toward New HIV Vaccines
Amanda B. Keener | Jan 27, 2017
A family of broadly neutralizing antibodies from a chronically infected donor provides a schematic for designing vaccines and treatments that target multiple strains of the virus.
Antibody Shows Promise For Combatting Diverse Strains Of HIV
Antibody Shows Promise For Combatting Diverse Strains Of HIV
Joshua A. Krisch | Nov 17, 2016
In preclinical trials, the N6 antibody neutralized 98 percent of 181 HIV strains tested.
USB Stick Rapidly Detects HIV
USB Stick Rapidly Detects HIV
Joshua A. Krisch | Nov 15, 2016
The prototype blood test could eventually be used to diagnose infections in resource-poor regions.
Five Oncoviruses Debut On NIH Carcinogen List
Five Oncoviruses Debut On NIH Carcinogen List
Joshua A. Krisch | Nov 7, 2016
Seven newly evaluated substances, including five oncoviruses, have been added to the US National Institutes of Health’s 14th Report on Carcinogens.
Week in Review: October 24–28
Week in Review: October 24–28
Bob Grant | Oct 27, 2016
Patient Zero exonerated; Jack Woodall dies; Wolbachia-harboring mosquitoes deployed in fight against Zika; implanted neurons function in adult mouse brain 
HIV Spread from Haiti to NYC in 1970, “Patient Zero” Not to Blame
HIV Spread from Haiti to NYC in 1970, “Patient Zero” Not to Blame
Ben Andrew Henry | Oct 26, 2016
Whole-genome sequencing of preserved blood samples provides the clearest picture to date of the virus’s arrival and spread in the U.S.
Broadly Neutralizing Antibodies in HIV Patients
Broadly Neutralizing Antibodies in HIV Patients
Jef Akst | Sep 28, 2016
Researchers identify aspects of the patient, the virus, and the infection itself that influence whether a person with HIV will produce broadly neutralizing antibodies.